Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves

April 23 (Reuters) - Edwards Lifesciences beat Wall Street first-quarter estimates on Thursday, driven by robust demand for its artificial valves used in complex cardiac procedures, sending its shares ...

Does Edwards Lifesciences’ TAVR Momentum and PASCAL, EVOQUE Adoption Reinforce Its Moat (EW)?

Edwards Lifesciences recently announced it would report its first-quarter 2026 results on April 23, with early commentary ...
MassDevice

Edwards announces new heart valve health initiative with David Letterman’s IndyCar racing team

Edwards Lifesciences (NYSE:EW) today unveiled its “Stay in the Race” initiative to support heart valve health.
KTLA

EISENHOWER HEALTH BECOMES FIRST EDWARDS BENCHMARK™ PROGRAM OBSERVATION SITE FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BEGINS HOSTING ...

RANCHO MIRAGE, Calif., Jan. 4, 2024 /PRNewswire/ -- Eisenhower Health is the first hospital in the United States to become an Edwards Benchmark program Case Observation Site for the treatment of ...
Business Wire

Edwards' Aortic Valve With Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in Seven Year Data

NEWBURY, England--(BUSINESS WIRE)--Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic ...
MassDevice

Edwards beats The Street in Q1, raises guidance

Edwards Lifesciences (NYSE:EW) today posted first-quarter financial results that came in ahead of the Wall Street forecast.
TCTMD

Edwards Lifesciences Receives FDA Approval for First Catheter-Based Aortic Heart Valve in the U.S.

IRVINE, CA, Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received approval from the United States Food and ...
TCTMD

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

IRVINE, CA. -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve ...